<unk>  differs from the sequence of Interleukin 1 receptor antagonist by one methionine amino acid added to its N-terminus; it also differs from the human protein in that it is not glycosylated, as it is manufactured in Escherichia coli.
Anakinra
Canakinumab
Sarilumab
Crofelemer
Tofacitinib
Ecallantide
Emapalumab
Anifrolumab